#BearcatsSaveLives: Hoxworth kicks off school year with UC all campus blood drive

This school year looks a little different during the COVID-19 pandemic, but Hoxworth Blood Center, University of Cincinnati still needs Bearcats to roll up their sleeves during the University of Cincinnati all-campus blood drive.  

Students, faculty, staff and fans of UC are encouraged to donate blood, platelets, or plasma during the drive in exchange for a $10 e-gift card and a free day pass from Red Bike.

The blood drive will be taking place on McMicken Commons from Monday, Sept. 21 through Friday, Sept. 25, with donor buses parked onsite from 10 a.m. to 5 p.m.

“The UC Campus definitely looks different this year, due to COVID-19,” said Jackie Marschall, spokesperson for Hoxworth. “But the need for blood doesn’t take a break, even for a pandemic. We’re thrilled that we are still able to hold blood drive at UC with extra safety precautions in place, and hope that the lifesaving Bearcats will come save lives with Hoxworth.”

Hoxworth will be hosting additional blood drives at UC Clermont on Monday, Sept. 21 and at UC Blue Ash on Wednesday, Sept. 23.

Marschall mentioned that Hoxworth needs to collect 400 units of blood and 50 units of platelets a day to fulfill the needs of local hospitals.

Appointments are encouraged to maintain proper social distancing, and masks are required of all donors. To schedule an appointment at any of the University of Cincinnati drives, visit www.hoxworth.org/uc or call 513-451-0910.

About Hoxworth:

Hoxworth Blood Center, University of Cincinnati was founded in 1938 and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky and Southeastern Indiana. Annually, Hoxworth collects more than 90,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home. 

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.